Literature DB >> 32038780

Oral Single Dose Toxicity Study of Low Molecular Fucoidan in Mice.

Young-Mi Jung1, Kang Min Yoo2, Dong-Chan Park1, Tae-Kwon Kim1, Hyeung-Sik Lee3, Sae-Kwang Ku4,5.   

Abstract

This study was conducted to obtain information of the oral dose toxicity of low molecular fucoidan (LMF) in male and female mice. In order to calculate 50% lethal dose (LD50) and approximate lethal dose (LD), test material was once orally administered to male and female ICR mice at dose levels of 2000, 1000, 500, 250, 125 and 0 (vehicle control) mg/kg (body wt.). The mortality and the changes on body weight, clinical signs, gross observation and organ weight and histopathology of principle organs were monitored 14 days after LMF treatment. We could not find any mortalities, clinical signs, body weight changes and gross findings. In addition, significant changes in the organ weight and histopathology of principal organs were not observed except for some sporadic findings. The results obtained in this study suggest that LMF may not be toxic in mice and may be therefore safe for clinical use. The LD50 and approximate LD in mice after single oral dose of LMF were considered over 2000 mg/kg in both female and male mice. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  Histopathology; Low molecular fucoidan; Mice; Single oral dose toxicity

Year:  2008        PMID: 32038780      PMCID: PMC7006321          DOI: 10.5487/TR.2008.24.1.079

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  20 in total

1.  Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells.

Authors:  Kiminori Matsubara; Changhu Xue; Xue Zhao; Masaharu Mori; Tatsuya Sugawara; Takashi Hirata
Journal:  Int J Mol Med       Date:  2005-04       Impact factor: 4.101

2.  Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells.

Authors:  Faouzia Zemani; Danielle Benisvy; Isabelle Galy-Fauroux; Anna Lokajczyk; Sylvia Colliec-Jouault; Georges Uzan; Anne Marie Fischer; Catherine Boisson-Vidal
Journal:  Biochem Pharmacol       Date:  2005-10-15       Impact factor: 5.858

3.  Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat.

Authors:  K Bojakowski; P Abramczyk; M Bojakowska; A Zwolińska; J Przybylski; Z Gaciong
Journal:  J Physiol Pharmacol       Date:  2001-03       Impact factor: 3.011

4.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

5.  Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse.

Authors:  S Irwin
Journal:  Psychopharmacologia       Date:  1968-09-20

6.  Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.

Authors:  Andrew C Lake; Roger Vassy; Mélanie Di Benedetto; Damien Lavigne; Catherine Le Visage; Gérard Y Perret; Didier Letourneur
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

7.  Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.

Authors:  Bassam Alkhatib; Caroline Freguin-Bouilland; Françoise Lallemand; Jean Paul Henry; Pierre-Yves Litzler; Jean Paul Marie; Vincent Richard; Christian Thuillez; Didier Plissonnier
Journal:  Transpl Immunol       Date:  2006-04-05       Impact factor: 1.708

8.  Effects of room temperature on reproduction, body and organ weights, food and water intakes, and hematology in mice.

Authors:  C Yamauchi; S Fujita; T Obara; T Ueda
Journal:  Jikken Dobutsu       Date:  1983-01

9.  Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.

Authors:  Caroline Fréguin-Bouilland; Bassam Alkhatib; Nathalie David; Françoise Lallemand; Jean-Paul Henry; Michel Godin; Christian Thuillez; Didier Plissonnier
Journal:  Transplantation       Date:  2007-05-15       Impact factor: 4.939

10.  Anticoagulant properties of a fucoïdan fraction.

Authors:  S Colliec; A M Fischer; J Tapon-Bretaudiere; C Boisson; P Durand; J Jozefonvicz
Journal:  Thromb Res       Date:  1991-10-15       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.